 | • レポートコード：D0804-09056 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、100ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ノンアルコール性脂肪性肝炎治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。ノンアルコール性脂肪性肝炎治療の種類別市場規模（固体、液体）、用途別市場規模（病院、診断センター、専門クリニック、病院薬局、ドラッグストア、通販薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：AstraZeneca、Cempra Pharmaceuticals、Novo Nordisk、Arena Pharmaceuticals、Arisaph Pharmaceuticals、GSK、Galmed Pharmaceuticals、Vivus、Roche、Galectin Therapeutics、Genfit、Gilead ・地域別グローバル市場分析 2015年-2020年 ・ノンアルコール性脂肪性肝炎治療の北米市場（アメリカ、カナダ、メキシコ） ・ノンアルコール性脂肪性肝炎治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ノンアルコール性脂肪性肝炎治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ノンアルコール性脂肪性肝炎治療の南米市場（ブラジル、アルゼンチン） ・ノンアルコール性脂肪性肝炎治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：固体、液体 ・用途別分析：病院、診断センター、専門クリニック、病院薬局、ドラッグストア、通販薬局 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Nonalcoholic Steatohepatitis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Nonalcoholic Steatohepatitis Treatment sales will be xx in 2020 from Nonalcoholic Steatohepatitis Treatment million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Nonalcoholic Steatohepatitis Treatment market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Nonalcoholic Steatohepatitis Treatment industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Nonalcoholic Steatohepatitis Treatment and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Nonalcoholic Steatohepatitis Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Nonalcoholic Steatohepatitis Treatment market has been segmented into
Solid
Liquid
By Application, Nonalcoholic Steatohepatitis Treatment has been segmented into:
Hospital
Diagnostic Center
Specialized Clinic
Hospital Pharmacy
Drug Store
Mail Order Pharmacy
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nonalcoholic Steatohepatitis Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Nonalcoholic Steatohepatitis Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nonalcoholic Steatohepatitis Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Nonalcoholic Steatohepatitis Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Nonalcoholic Steatohepatitis Treatment Market Share Analysis
Nonalcoholic Steatohepatitis Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nonalcoholic Steatohepatitis Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nonalcoholic Steatohepatitis Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Nonalcoholic Steatohepatitis Treatment are:
AstraZeneca
Cempra Pharmaceuticals
Novo Nordisk
Arena Pharmaceuticals
Arisaph Pharmaceuticals
GSK
Galmed Pharmaceuticals
Vivus
Roche
Galectin Therapeutics
Genfit
Gilead
Among other players domestic and global, Nonalcoholic Steatohepatitis Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nonalcoholic Steatohepatitis Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nonalcoholic Steatohepatitis Treatment, with price, sales, revenue and global market share of Nonalcoholic Steatohepatitis Treatment in 2018 and 2019.
Chapter 3, the Nonalcoholic Steatohepatitis Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nonalcoholic Steatohepatitis Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Nonalcoholic Steatohepatitis Treatment market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Nonalcoholic Steatohepatitis Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Nonalcoholic Steatohepatitis Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nonalcoholic Steatohepatitis Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Solid
1.2.3 Liquid
1.3 Market Analysis by Application
1.3.1 Overview: Global Nonalcoholic Steatohepatitis Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Specialized Clinic
1.3.5 Hospital Pharmacy
1.3.6 Drug Store
1.3.7 Mail Order Pharmacy
1.4 Overview of Global Nonalcoholic Steatohepatitis Treatment Market
1.4.1 Global Nonalcoholic Steatohepatitis Treatment Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Nonalcoholic Steatohepatitis Treatment Industry Impact
1.6.1 COVID-19 Potential Implications for the Nonalcoholic Steatohepatitis Treatment
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Nonalcoholic Steatohepatitis Treatment
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AstraZeneca SWOT Analysis
2.1.4 AstraZeneca Product and Services
2.1.5 AstraZeneca Nonalcoholic Steatohepatitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Cempra Pharmaceuticals
2.2.1 Cempra Pharmaceuticals Details
2.2.2 Cempra Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Cempra Pharmaceuticals SWOT Analysis
2.2.4 Cempra Pharmaceuticals Product and Services
2.2.5 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novo Nordisk
2.3.1 Novo Nordisk Details
2.3.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novo Nordisk SWOT Analysis
2.3.4 Novo Nordisk Product and Services
2.3.5 Novo Nordisk Nonalcoholic Steatohepatitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Arena Pharmaceuticals
2.4.1 Arena Pharmaceuticals Details
2.4.2 Arena Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Arena Pharmaceuticals SWOT Analysis
2.4.4 Arena Pharmaceuticals Product and Services
2.4.5 Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Arisaph Pharmaceuticals
2.5.1 Arisaph Pharmaceuticals Details
2.5.2 Arisaph Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Arisaph Pharmaceuticals SWOT Analysis
2.5.4 Arisaph Pharmaceuticals Product and Services
2.5.5 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 GSK
2.6.1 GSK Details
2.6.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GSK SWOT Analysis
2.6.4 GSK Product and Services
2.6.5 GSK Nonalcoholic Steatohepatitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Galmed Pharmaceuticals
2.7.1 Galmed Pharmaceuticals Details
2.7.2 Galmed Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Galmed Pharmaceuticals SWOT Analysis
2.7.4 Galmed Pharmaceuticals Product and Services
2.7.5 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Vivus
2.8.1 Vivus Details
2.8.2 Vivus Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Vivus SWOT Analysis
2.8.4 Vivus Product and Services
2.8.5 Vivus Nonalcoholic Steatohepatitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Roche SWOT Analysis
2.9.4 Roche Product and Services
2.9.5 Roche Nonalcoholic Steatohepatitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Galectin Therapeutics
2.10.1 Galectin Therapeutics Details
2.10.2 Galectin Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Galectin Therapeutics SWOT Analysis
2.10.4 Galectin Therapeutics Product and Services
2.10.5 Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Genfit
2.11.1 Genfit Details
2.11.2 Genfit Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Genfit SWOT Analysis
2.11.4 Genfit Product and Services
2.11.5 Genfit Nonalcoholic Steatohepatitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Gilead
2.12.1 Gilead Details
2.12.2 Gilead Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Gilead SWOT Analysis
2.12.4 Gilead Product and Services
2.12.5 Gilead Nonalcoholic Steatohepatitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Nonalcoholic Steatohepatitis Treatment Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Nonalcoholic Steatohepatitis Treatment Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Nonalcoholic Steatohepatitis Treatment Manufacturer Market Share in 2019
3.3.2 Top 6 Nonalcoholic Steatohepatitis Treatment Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Nonalcoholic Steatohepatitis Treatment Sales and Market Share by Regions (2015-2020)
4.1.2 Global Nonalcoholic Steatohepatitis Treatment Revenue and Market Share by Regions (2015-2020)
4.2 North America Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
4.3 Europe Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
4.5 South America Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Market Share by Country
5.1.1 North America Nonalcoholic Steatohepatitis Treatment Sales and Market Share by Country (2015-2020)
5.1.2 North America Nonalcoholic Steatohepatitis Treatment Revenue and Market Share by Country (2015-2020)
5.2 United States Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
5.3 Canada Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
5.4 Mexico Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Market Share by Country
6.1.1 Europe Nonalcoholic Steatohepatitis Treatment Sales and Market Share by Country (2015-2020)
6.1.2 Europe Nonalcoholic Steatohepatitis Treatment Revenue and Market Share by Country (2015-2020)
6.2 Germany Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
6.3 UK Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
6.4 France Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
6.5 Russia Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
6.6 Italy Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Nonalcoholic Steatohepatitis Treatment Revenue and Market Share by Regions (2015-2020)
7.2 China Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
7.3 Japan Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
7.4 Korea Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
7.5 India Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
7.7 Australia Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Market Share by Country
8.1.1 South America Nonalcoholic Steatohepatitis Treatment Sales and Market Share by Country (2015-2020)
8.1.2 South America Nonalcoholic Steatohepatitis Treatment Revenue and Market Share by Country (2015-2020)
8.2 Brazil Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
8.3 Argentina Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Nonalcoholic Steatohepatitis Treatment Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Nonalcoholic Steatohepatitis Treatment Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
9.3 Turkey Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
9.4 Egypt Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
9.5 South Africa Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Nonalcoholic Steatohepatitis Treatment Sales and Market Share by Type (2015-2020)
10.2 Global Nonalcoholic Steatohepatitis Treatment Revenue and Market Share by Type (2015-2020)
10.3 Global Nonalcoholic Steatohepatitis Treatment Price by Type (2015-2020)
11 Global Nonalcoholic Steatohepatitis Treatment Market Segment by Application
11.1 Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application (2015-2020)
11.2 Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Application (2015-2020)
11.3 Global Nonalcoholic Steatohepatitis Treatment Price by Application (2015-2020)
12 Market Forecast
12.1 Global Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Growth Rate (2021-2025)
12.2 Nonalcoholic Steatohepatitis Treatment Market Forecast by Regions (2021-2025)
12.2.1 North America Nonalcoholic Steatohepatitis Treatment Market Forecast (2021-2025)
12.2.2 Europe Nonalcoholic Steatohepatitis Treatment Market Forecast (2021-2025)
12.2.3 Asia-Pacific Nonalcoholic Steatohepatitis Treatment Market Forecast (2021-2025)
12.2.4 South America Nonalcoholic Steatohepatitis Treatment Market Forecast (2021-2025)
12.2.5 Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Forecast (2021-2025)
12.3 Nonalcoholic Steatohepatitis Treatment Market Forecast by Type (2021-2025)
12.3.1 Global Nonalcoholic Steatohepatitis Treatment Sales Forecast by Type (2021-2025)
12.3.2 Global Nonalcoholic Steatohepatitis Treatment Market Share Forecast by Type (2021-2025)
12.4 Nonalcoholic Steatohepatitis Treatment Market Forecast by Application (2021-2025)
12.4.1 Global Nonalcoholic Steatohepatitis Treatment Sales Forecast by Application (2021-2025)
12.4.2 Global Nonalcoholic Steatohepatitis Treatment Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Nonalcoholic Steatohepatitis Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nonalcoholic Steatohepatitis Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nonalcoholic Steatohepatitis Treatment Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Nonalcoholic Steatohepatitis Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 9. AstraZeneca Nonalcoholic Steatohepatitis Treatment Major Business
Table 10. AstraZeneca Nonalcoholic Steatohepatitis Treatment Total Revenue (USD Million) (2018-2019)
Table 11. AstraZeneca SWOT Analysis
Table 12. AstraZeneca Nonalcoholic Steatohepatitis Treatment Product and Services
Table 13. AstraZeneca Nonalcoholic Steatohepatitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Cempra Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 15. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Major Business
Table 16. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Total Revenue (USD Million) (2018-2019)
Table 17. Cempra Pharmaceuticals SWOT Analysis
Table 18. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product and Services
Table 19. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 21. Novo Nordisk Nonalcoholic Steatohepatitis Treatment Major Business
Table 22. Novo Nordisk Nonalcoholic Steatohepatitis Treatment Total Revenue (USD Million) (2018-2019)
Table 23. Novo Nordisk SWOT Analysis
Table 24. Novo Nordisk Nonalcoholic Steatohepatitis Treatment Product and Services
Table 25. Novo Nordisk Nonalcoholic Steatohepatitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Arena Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 27. Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Major Business
Table 28. Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Total Revenue (USD Million) (2018-2019)
Table 29. Arena Pharmaceuticals SWOT Analysis
Table 30. Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product and Services
Table 31. Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Arisaph Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 33. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Major Business
Table 34. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Total Revenue (USD Million) (2018-2019)
Table 35. Arisaph Pharmaceuticals SWOT Analysis
Table 36. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product and Services
Table 37. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. GSK Basic Information, Manufacturing Base and Competitors
Table 39. GSK Nonalcoholic Steatohepatitis Treatment Major Business
Table 40. GSK Nonalcoholic Steatohepatitis Treatment Total Revenue (USD Million) (2018-2019)
Table 41. GSK SWOT Analysis
Table 42. GSK Nonalcoholic Steatohepatitis Treatment Product and Services
Table 43. GSK Nonalcoholic Steatohepatitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Galmed Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 45. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Major Business
Table 46. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Total Revenue (USD Million) (2018-2019)
Table 47. Galmed Pharmaceuticals SWOT Analysis
Table 48. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product and Services
Table 49. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Vivus Basic Information, Manufacturing Base and Competitors
Table 51. Vivus Nonalcoholic Steatohepatitis Treatment Major Business
Table 52. Vivus Nonalcoholic Steatohepatitis Treatment Total Revenue (USD Million) (2018-2019)
Table 53. Vivus SWOT Analysis
Table 54. Vivus Nonalcoholic Steatohepatitis Treatment Product and Services
Table 55. Vivus Nonalcoholic Steatohepatitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Roche Basic Information, Manufacturing Base and Competitors
Table 57. Roche Nonalcoholic Steatohepatitis Treatment Major Business
Table 58. Roche Nonalcoholic Steatohepatitis Treatment Total Revenue (USD Million) (2018-2019)
Table 59. Roche SWOT Analysis
Table 60. Roche Nonalcoholic Steatohepatitis Treatment Product and Services
Table 61. Roche Nonalcoholic Steatohepatitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Galectin Therapeutics Basic Information, Manufacturing Base and Competitors
Table 63. Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Major Business
Table 64. Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Total Revenue (USD Million) (2018-2019)
Table 65. Galectin Therapeutics SWOT Analysis
Table 66. Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Product and Services
Table 67. Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Genfit Basic Information, Manufacturing Base and Competitors
Table 69. Genfit Nonalcoholic Steatohepatitis Treatment Major Business
Table 70. Genfit Nonalcoholic Steatohepatitis Treatment Total Revenue (USD Million) (2018-2019)
Table 71. Genfit SWOT Analysis
Table 72. Genfit Nonalcoholic Steatohepatitis Treatment Product and Services
Table 73. Genfit Nonalcoholic Steatohepatitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Gilead Basic Information, Manufacturing Base and Competitors
Table 75. Gilead Nonalcoholic Steatohepatitis Treatment Major Business
Table 76. Gilead Nonalcoholic Steatohepatitis Treatment Total Revenue (USD Million) (2018-2019)
Table 77. Gilead SWOT Analysis
Table 78. Gilead Nonalcoholic Steatohepatitis Treatment Product and Services
Table 79. Gilead Nonalcoholic Steatohepatitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Global Nonalcoholic Steatohepatitis Treatment Sales by Manufacturer (2018-2019) (K Units)
Table 81. Global Nonalcoholic Steatohepatitis Treatment Revenue by Manufacturer (2018-2019) (USD Million)
Table 82. Global Nonalcoholic Steatohepatitis Treatment Sales by Regions (2015-2020) (K Units)
Table 83. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Regions (2015-2020)
Table 84. Global Nonalcoholic Steatohepatitis Treatment Revenue by Regions (2015-2020) (USD Million)
Table 85. North America Nonalcoholic Steatohepatitis Treatment Sales by Countries (2015-2020) (K Units)
Table 86. North America Nonalcoholic Steatohepatitis Treatment Sales Market Share by Countries (2015-2020)
Table 87. North America Nonalcoholic Steatohepatitis Treatment Revenue by Countries (2015-2020) (USD Million)
Table 88. North America Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Countries (2015-2020)
Table 89. Europe Nonalcoholic Steatohepatitis Treatment Sales by Countries (2015-2020) (K Units)
Table 90. Europe Nonalcoholic Steatohepatitis Treatment Sales Market Share by Countries (2015-2020)
Table 91. Europe Nonalcoholic Steatohepatitis Treatment Revenue by Countries (2015-2020) (USD Million)
Table 92. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales by Regions (2015-2020) (K Units)
Table 93. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales Market Share by Regions (2015-2020)
Table 94. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Revenue by Regions (2015-2020) (USD Million)
Table 95. South America Nonalcoholic Steatohepatitis Treatment Sales by Countries (2015-2020) (K Units)
Table 96. South America Nonalcoholic Steatohepatitis Treatment Sales Market Share by Countries (2015-2020)
Table 97. South America Nonalcoholic Steatohepatitis Treatment Revenue by Countries (2015-2020) (USD Million)
Table 98. South America Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Countries (2015-2020)
Table 99. Middle East & Africa Nonalcoholic Steatohepatitis Treatment Sales by Countries (2015-2020) (K Units)
Table 100. Middle East & Africa Nonalcoholic Steatohepatitis Treatment Sales Market Share by Countries (2015-2020)
Table 101. Middle East & Africa Nonalcoholic Steatohepatitis Treatment Revenue by Countries (2015-2020) (USD Million)
Table 102. Middle East & Africa Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Countries (2015-2020)
Table 103. Global Nonalcoholic Steatohepatitis Treatment Sales by Type (2015-2020) (K Units)
Table 104. Global Nonalcoholic Steatohepatitis Treatment Sales Share by Type (2015-2020)
Table 105. Global Nonalcoholic Steatohepatitis Treatment Revenue by Type (2015-2020) (USD Million)
Table 106. Global Nonalcoholic Steatohepatitis Treatment Revenue Share by Type (2015-2020)
Table 107. Global Nonalcoholic Steatohepatitis Treatment Sales by Application (2015-2020) (K Units)
Table 108. Global Nonalcoholic Steatohepatitis Treatment Sales Share by Application (2015-2020)
Table 109. Global Nonalcoholic Steatohepatitis Treatment Sales Forecast by Regions (2021-2025) (K Units)
Table 110. Global Nonalcoholic Steatohepatitis Treatment Market Share Forecast by Regions (2021-2025)
Table 111. Global Nonalcoholic Steatohepatitis Treatment Sales Forecast by Type (2021-2025) (K Units)
Table 112. Global Nonalcoholic Steatohepatitis Treatment Market Share Forecast by Type (2021-2025)
Table 113. Global Nonalcoholic Steatohepatitis Treatment Sales Forecast by Application (2021-2025)
Table 114. Global Nonalcoholic Steatohepatitis Treatment Market Share Forecast by Application (2021-2025)
Table 115. Direct Channel Pros & Cons
Table 116. Indirect Channel Pros & Cons
Table 117. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Nonalcoholic Steatohepatitis Treatment Picture
Figure 2. Global Sales Market Share of Nonalcoholic Steatohepatitis Treatment by Type in 2019
Figure 3. Solid Picture
Figure 4. Liquid Picture
Figure 5. Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application in 2018
Figure 6. Hospital Picture
Figure 7. Diagnostic Center Picture
Figure 8. Specialized Clinic Picture
Figure 9. Hospital Pharmacy Picture
Figure 10. Drug Store Picture
Figure 11. Mail Order Pharmacy Picture
Figure 12. Global Nonalcoholic Steatohepatitis Treatment Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Nonalcoholic Steatohepatitis Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Nonalcoholic Steatohepatitis Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Nonalcoholic Steatohepatitis Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Nonalcoholic Steatohepatitis Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Nonalcoholic Steatohepatitis Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Nonalcoholic Steatohepatitis Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Nonalcoholic Steatohepatitis Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Nonalcoholic Steatohepatitis Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Nonalcoholic Steatohepatitis Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Nonalcoholic Steatohepatitis Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Nonalcoholic Steatohepatitis Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Nonalcoholic Steatohepatitis Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Nonalcoholic Steatohepatitis Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Nonalcoholic Steatohepatitis Treatment Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Nonalcoholic Steatohepatitis Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Nonalcoholic Steatohepatitis Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Nonalcoholic Steatohepatitis Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Nonalcoholic Steatohepatitis Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Nonalcoholic Steatohepatitis Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Manufacturer in 2019
Figure 33. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Nonalcoholic Steatohepatitis Treatment Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Nonalcoholic Steatohepatitis Treatment Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 38. Global Nonalcoholic Steatohepatitis Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Regions (2015-2020)
Figure 40. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Regions in 2018
Figure 41. North America Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
Figure 42. Europe Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
Figure 44. South America Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020)
Figure 46. North America Nonalcoholic Steatohepatitis Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Nonalcoholic Steatohepatitis Treatment Sales Market Share by Countries (2015-2020)
Figure 48. North America Nonalcoholic Steatohepatitis Treatment Sales Market Share by Countries in 2018
Figure 49. North America Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Countries in 2018
Figure 51. United States Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Canada Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Mexico Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Europe Nonalcoholic Steatohepatitis Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Countries in 2019
Figure 57. Germany Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 58. UK Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 59. France Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Russia Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Italy Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Regions 2019
Figure 65. China Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Japan Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Korea Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 68. India Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Southeast Asia Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 70. South America Nonalcoholic Steatohepatitis Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Nonalcoholic Steatohepatitis Treatment Sales Market Share by Countries in 2019
Figure 72. South America Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Countries in 2019
Figure 73. Brazil Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Argentina Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Egypt Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Turkey Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 82. South Africa Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Global Nonalcoholic Steatohepatitis Treatment Sales and Growth Rate (2021-2025) (K Units)
Figure 84. Global Nonalcoholic Steatohepatitis Treatment Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Nonalcoholic Steatohepatitis Treatment Market Forecast (2021-2025) (K Units)
Figure 86. Europe Sales Nonalcoholic Steatohepatitis Treatment Market Forecast (2021-2025) (K Units)
Figure 87. Asia-Pacific Sales Nonalcoholic Steatohepatitis Treatment Market Forecast (2021-2025) (K Units)
Figure 88. South America Sales Nonalcoholic Steatohepatitis Treatment Market Forecast (2021-2025) (K Units)
Figure 89. Middle East & Africa Sales Nonalcoholic Steatohepatitis Treatment Market Forecast (2021-2025) (K Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
ノンアルコール性脂肪性肝炎（NASH）治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Non-Alcoholic Steatohepatitis (NASH) Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. Th…- ノンアルコール性脂肪性肝炎（NASH）治療及び診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Non-Alcoholic Steatohepatitis (NASH) Therapeutics and Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and glob…
- 非薬物療法うつ病治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Drug Free Depression Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Drug Free Depr…
- 子宮頸部ジストニア治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Cervical Dystonia Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- 夜間多尿治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Nocturnal Polyuria Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…